BiomX Inc. (PHGE)
Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 20262 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to BiomX Inc.’s names, not what it holds today.
8 published
5 published
Names not counted (2)
| Granted | Patent | Title | Field | Owner as printed |
|---|---|---|---|---|
| Jun 11, 2024 | 12,006,517 | Method for purification of bacteriophage particles | Chemical engineering | Adaptive Phage Therapeutics, Inc. |
| Feb 27, 2024 | 11,911,345 | Phage dispensing system | Medical technology | Adaptive Phage Therapeutics, Inc. |
| Published | Application | Title | Field | Owner as printed |
|---|---|---|---|---|
| Jan 16, 2025 | 2025/0017824 | PHAGE DISPENSING SYSTEM | Medical technology | Adaptive Phage Therapeutics, Inc. |
| Aug 22, 2024 | 2024/0279620 | METHOD FOR PURIFICATION OF BACTERIOPHAGE PARTICLES | Chemical engineering | Adaptive Phage Therapeutics, Inc. |
| Apr 25, 2024 | 2024/0132933 | IMPROVED ANTI-BIOFILM ASSAY METHODS | Analysis of biological materials | Adaptive Phage Therapeutics, Inc. |
| Apr 4, 2024 | 2024/0108551 | PHAGE DISPENSING SYSTEM | Medical technology | Adaptive Phage Therapeutics, Inc. |
| Dec 14, 2023 | 2023/0400460 | COMPUTER IMPLEMENTED METHOD FOR ANALYZING HOST PHAGE RESPONSE DATA | Analysis of biological materials | Adaptive Phage Therapeutics, Inc. |
| Mar 16, 2023 | 2023/0084687 | SYSTEM AND METHOD TO SELECT PHAGE THERAPY BASED ON TIME AND LOCATION | Medical technology | Adaptive Phage Therapeutics, Inc. |
| Feb 16, 2023 | 2023/0046598 | MACHINE LEARNING SYSTEM FOR INTERPRETING HOST PHAGE RESPONSE | Computer technology | Adaptive Phage Therapeutics, Inc. |
| Apr 28, 2022 | 2022/0127583 | METHOD FOR PURIFICATION OF BACTERIOPHAGE PARTICLES | Chemical engineering | Adaptive Phage Therapeutics, Inc. · patent 12,006,517 granted from it |
| Dec 2, 2021 | 2021/0369635 | NOVEL METHODS OF VACCINATION USING ICOSAHEDRAL PHAGE | Pharmaceuticals | Adaptive Phage Therapeutics, Inc. |
| Oct 28, 2021 | 2021/0332419 | MONITORING HOST CELL CONTAMINATION OF VIRUS-BASED BIOLOGICAL PRODUCTS | Analysis of biological materials | Adaptive Phage Therapeutics, Inc. |
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.